
Ibs B342
About
Ibs B342 is a hybrid cannabis strain. Lab samples test between 20.0% and 27.1% THC, with myrcene (0.80%) as the dominant terpene.
Why does Ibs B342 have these effects?
Ibs B342's effects are driven by its dominant myrcene (0.80%), which has sedative and muscle-relaxant properties, combined with caryophyllene (0.63%), one of the few terpenes that binds directly to CB2 cannabinoid receptors.
Strain Profile
May Help With
Caryophyllene has strong anti-inflammatory properties
Myrcene has analgesic and muscle-relaxant properties
Linalool has calming, stress-relieving properties
Linalool is known for anti-anxiety effects
Based on terpene research and reported effects. Not medical advice. Consult a healthcare professional for medical decisions.
Similar Strains
Strains with a similar profile you might enjoy
Quick Info
- Type
- hybrid
- Breeder
- Not verified
- THC
- 20.0–27.1%
- CBD
- 0.1%
- Chemotype
- Myrcene-dominant
What is Myrcene?
The most common cannabis terpene, also found in mangoes, hops, and lemongrass.
Learn more →
← Back to all strainsAbout Ibs B342
- Ibs B342 is a hybrid cannabis strain. Hybrids combine characteristics of both indica and sativa genetics.
- Ibs B342 typically tests at 20.0% to 27.1% THC. This is considered a high-potency strain, so start with a low dose if you are new to it.
- The dominant terpenes in Ibs B342 are Myrcene, Caryophyllene, Limonene. Terpenes influence the aroma, flavor, and effects of a cannabis strain.
